GR3035616T3 - Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods. - Google Patents

Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods.

Info

Publication number
GR3035616T3
GR3035616T3 GR20010400462T GR20010400462T GR3035616T3 GR 3035616 T3 GR3035616 T3 GR 3035616T3 GR 20010400462 T GR20010400462 T GR 20010400462T GR 20010400462 T GR20010400462 T GR 20010400462T GR 3035616 T3 GR3035616 T3 GR 3035616T3
Authority
GR
Greece
Prior art keywords
cyclic gmp
methods
binding
specific phosphodiesterase
cgb
Prior art date
Application number
GR20010400462T
Other languages
English (en)
Inventor
Joseph A Beavo
Jackie D Corbin
Kenneth M Ferguson
Sharron H Francis
Ann Kadlecek
Kate Loughney
Linda M Mcallister-Lucas
William K Sonnenburg
Melissa K Thomas
Original Assignee
Univ Washington
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22080121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3035616(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington, Icos Corp filed Critical Univ Washington
Publication of GR3035616T3 publication Critical patent/GR3035616T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Saccharide Compounds (AREA)
GR20010400462T 1993-05-27 2001-03-21 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods. GR3035616T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6805193A 1993-05-27 1993-05-27
PCT/US1994/006066 WO1994028144A1 (en) 1993-05-27 1994-05-27 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods

Publications (1)

Publication Number Publication Date
GR3035616T3 true GR3035616T3 (en) 2001-06-29

Family

ID=22080121

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400462T GR3035616T3 (en) 1993-05-27 2001-03-21 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods.

Country Status (13)

Country Link
US (7) US5702936A (el)
EP (2) EP1038963B1 (el)
JP (3) JP4150070B2 (el)
AT (2) ATE438723T1 (el)
CA (3) CA2698716A1 (el)
DE (3) DE69426804D1 (el)
DK (2) DK1038963T3 (el)
ES (2) ES2333691T3 (el)
GR (1) GR3035616T3 (el)
HK (1) HK1013427A1 (el)
LV (1) LV12814B (el)
PT (2) PT652960E (el)
WO (1) WO1994028144A1 (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060222647A1 (en) * 1993-05-27 2006-10-05 Beavo Joseph A Methods and compositions for modulating the activity of PDE5
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
AU3307999A (en) * 1998-02-23 1999-09-06 Icos Corporation Phosphodiesterase 10
CA2334942A1 (en) * 1998-07-21 2000-02-03 Takeda Chemical Industries, Ltd. Novel protein and its dna
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
AU1833000A (en) * 1998-11-25 2000-06-19 Cell Pathways, Inc. Method for diagnosing neoplasia
US6100037A (en) * 1999-01-07 2000-08-08 Incyte Pharmaceuticals, Inc. Human cyclic nucleotide PDEs
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
US7098015B2 (en) * 1999-06-11 2006-08-29 Millennium Pharmaceuticals, Inc. 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
US6146876A (en) * 1999-06-11 2000-11-14 Millennium Pharmaceuticals, Inc. 22025, a novel human cyclic nucleotide phosphodiesterase
GB9922125D0 (en) 1999-09-17 1999-11-17 Pfizer Ltd Phosphodiesterase enzymes
CN1297049A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人环磷酸鸟嘌呤抑制的磷酸二酯酶17和编码这种多肽的多核苷酸
CA2407031A1 (en) 2000-04-19 2001-10-25 Lilly Icos Llc Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
US6794192B2 (en) 2000-06-29 2004-09-21 Pfizer Inc. Target
GB0016009D0 (en) * 2000-06-29 2000-08-23 Pfizer Ltd Target
US6846813B2 (en) * 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
US20030096864A1 (en) * 2000-06-30 2003-05-22 Fang Lawrence Y. Compounds to treat alzheimer's disease
EP1317564B1 (en) * 2000-09-14 2007-08-01 Mount Sinai School of Medicine Screening methods to identify g-proteins and other compounds which modulate phosphodiesterase (pde) activity
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US20040219632A1 (en) * 2001-04-20 2004-11-04 Robert Margolskee T1r3 a novel taste receptor
US20070213407A1 (en) * 2001-06-29 2007-09-13 Elan Pharmaceuticals And Pharmacia & Upjohn Company Llc Compounds to treat Alzheimer's disease
US20030207834A1 (en) * 2001-07-10 2003-11-06 Dale Roderic M.K. Oligonucleotide-containing pharmacological compositions and their use
GB0126417D0 (en) * 2001-11-02 2002-01-02 Pfizer Ltd Crystal structure
US20050202549A1 (en) * 2001-11-02 2005-09-15 Pfizer Inc Crystal structure
US7304128B2 (en) 2002-06-04 2007-12-04 E.I. Du Pont De Nemours And Company Carbon nanotube binding peptides
BRPI0409931A (pt) * 2003-05-01 2006-04-25 Pfizer cristal de pde5, sua estrutura de cristal e seu em projeto de droga
JP2010004758A (ja) * 2008-06-24 2010-01-14 Probex Inc ｃｙｃｌｉｃＧＭＰ検出方法
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
KR101550217B1 (ko) * 2014-03-26 2015-09-04 전남대학교산학협력단 숙주세포의 생체 회로 간섭 없이 외래 유전자를 발현하기 위한 재조합 벡터 및 이의 용도
WO2017094885A1 (ja) * 2015-12-04 2017-06-08 国立大学法人東京大学 リガンド蛍光センサータンパク質とその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1290210B (de) * 1962-12-04 1969-03-06 Siemens Ag Vorrichtung zum maschinellen Verlegen und Anschliessen von Schaltdraehten
US4129349A (en) * 1975-11-10 1978-12-12 Bell Telephone Laboratories, Incorporated Quick-connect breadboarding system
JPH0797015B2 (ja) * 1988-10-28 1995-10-18 株式会社ピーエフユー 画像処理によるｓｍｄの位置補正方式
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
JPH038400A (ja) * 1989-06-06 1991-01-16 Sharp Corp プリント基板の位置補正方法
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
US5015637A (en) * 1990-05-25 1991-05-14 Hoechst-Roussel Pharmaceutical Inc. Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines
DE69233214T2 (de) * 1991-04-19 2004-07-01 The Board Of Regents Of The University Of Washington, Seattle Für säugetierphosphodiesterasen kodierende dns
WO1993005182A1 (en) * 1991-09-05 1993-03-18 Isis Pharmaceuticals, Inc. Determination of oligonucleotides for therapeutics, diagnostics and research reagents
US6403302B1 (en) * 1992-09-17 2002-06-11 California Institute Of Technology Methods and compositions for triple helix formation

Also Published As

Publication number Publication date
EP0652960B1 (en) 2001-03-07
CA2141060C (en) 2002-02-19
US20030054992A1 (en) 2003-03-20
DE69426804T4 (de) 2005-10-13
US5652131A (en) 1997-07-29
US6037119A (en) 2000-03-14
JP4450767B2 (ja) 2010-04-14
CA2363537C (en) 2010-07-06
ATE438723T1 (de) 2009-08-15
HK1013427A1 (en) 1999-08-27
EP1038963A2 (en) 2000-09-27
EP0652960A1 (en) 1995-05-17
PT652960E (pt) 2001-08-30
US20060216809A1 (en) 2006-09-28
CA2141060A1 (en) 1994-12-08
JP2005245467A (ja) 2005-09-15
DE69435227D1 (de) 2009-09-17
EP0652960B9 (en) 2004-10-27
DE69426804T2 (de) 2001-07-19
JP4150070B2 (ja) 2008-09-17
ES2156898T3 (es) 2001-08-01
ES2333691T3 (es) 2010-02-26
US5702936A (en) 1997-12-30
EP1038963B1 (en) 2009-08-05
JPH08502900A (ja) 1996-04-02
US5955583A (en) 1999-09-21
WO1994028144A1 (en) 1994-12-08
LV12814B (lv) 2002-10-20
LV12814A (en) 2002-04-20
JP2010042035A (ja) 2010-02-25
DE69426804D1 (de) 2001-04-12
CA2363537A1 (en) 1994-12-08
EP1038963A3 (en) 2000-10-04
DK1038963T3 (da) 2009-11-23
US20050196833A1 (en) 2005-09-08
CA2698716A1 (en) 1994-12-08
ATE199569T1 (de) 2001-03-15
DK0652960T3 (da) 2001-04-17
PT1038963E (pt) 2009-10-13

Similar Documents

Publication Publication Date Title
HK1013427A1 (en) Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
HK1013297A1 (en) Dna encoding mammalian phosphodiesterases
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
IL195812A0 (en) Human tslp dna and polypeptides
EP1903112A3 (en) Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family
AU3498189A (en) Fibronectin binding protein
HK1024933A1 (en) Mutant penicillin g acylases
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
EP0546087A4 (el)
AU5727099A (en) A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme
EP1010761A4 (en) UNCOMFORTABLE
EP0551750A3 (en) Recombinant dna compounds and expression vectors encoding para-nitrobenzyl esterase activity from bacillus
EP0897011A3 (en) Novel arginine deiminase
MX9700940A (es) Quimiocina derivada de macrofagos y analogos de quimiocina.